Detalhe da pesquisa
1.
A Pragmatic Randomized Feasibility Trial of Influenza Vaccines.
NEJM Evid;
2(2): EVIDoa2200206, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38320035
2.
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial.
Pilot Feasibility Stud;
8(1): 87, 2022 Apr 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35449028
3.
Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.
BMC Med;
7: 13, 2009 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19341446
4.
Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis.
Expert Rev Vaccines;
18(3): 295-308, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30689467
5.
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.
Hum Vaccin Immunother;
14(3): 596-608, 2018 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28968138
6.
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.
Vaccine;
31(47): 5572-8, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24016810
7.
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
Vaccine;
26(51): 6614-9, 2008 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18930093
8.
Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip.
Vaccine;
24(10): 1586-92, 2006 Mar 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16271424